Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2012.04761.x/fullpdf
Reference20 articles.
1. Prevalence of stroke and related burden among older people living in Latin America, India and China;Ferri;J Neurol Neurosurg Psychiatry,2011
2. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review;Feigin;Lancet Neurol,2009
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke;N Engl J Med,1995
4. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study;Wahlgren;Lancet,2007
5. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT);Yamaguchi;Stroke,2006
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of Effectiveness and Safety of Low-Dose Versus Standard-Dose Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke: A Meta-Analysis;Cureus;2023-02-28
2. Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis;Frontiers in Neurology;2022-06-23
3. Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan;Journal of the American Heart Association;2022-02
4. Intravenous thrombolysis in ischemic stroke patients with a prior intracranial hemorrhage: a meta-analysis;Therapeutic Advances in Neurological Disorders;2022-01
5. Worse prognosis in women, compared with men, after thrombolysis: An individual patient data pooling study of Asian acute stroke registries;International Journal of Stroke;2020-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3